Table 4.
Coronavirus disease 2019 (COVID-19) outcomes in patients with rheumatic diseases.
| Outcome | RD with COVID-19 (n = 196) |
||
|---|---|---|---|
| IA (n = 139) |
CTDs (n = 57) |
p | |
| Hospitalization | 48 (34.5) | 25 (43.9) | 0.14 |
| ICU care | 12 (8.6) | 9 (15.8) | 0.11 |
| Need to MV | 10 (7.2) | 3 (5.3) | 0.6 |
| Mortality | 11 (7.9) | 4 (7.0) | 0.55 |
| Flare of RD | 14 (10.8) | 18 (31.6) | 0.04 |
IA: inflammatory arthritis including rheumatoid arthritis, seronegative spondyloarthritis and undifferentiated inflammatory arthritis; CTDs: connective tissue diseases including SLE: systemic lupus erythematosus, vasculitis and others, ICU: intensive care unit, MV: mechanical ventilation. Bold values are significant at p < 0.05.